Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Oligogen, Inc. logo — Oligogen, Inc. is a biotech startup developing stem cell the...

Oligogen, Inc.

Oligogen, Inc. is a biotech startup developing stem cell therapies for central nervous system diseases.

Founded 2015 Japan Japan 1 employees Venture round Total: $111.05M Biotechnology, Care Economy +2

General Information

Company Name Oligogen, Inc.
Founded Year 2015
Location Japan Japan
Employees 1
Industries Biotechnology, Care Economy, Health and Wellness +1
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Oligogen, Inc.. To contact Oligogen, Inc., visit oligogen.jp.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Oligogen, Inc.

Oligogen, Inc. is a Japanese biotech startup founded in 2015 with a focus on developing stem cell therapies for central nervous system (CNS) diseases. The company's patented neural stem cell technology “OligoGenie” has garnered global recognition, with patents in over 29 countries. Oligogen, Inc. has made significant strides in its pre-clinical phase for several pipeline diseases. The startup recently secured a substantial ¥111.05M Venture Round investment on 10 August 2017, attracting notable investors such as Nissay Capital, SMBC Venture Capital, Sosei CVC, and Kyoto University Innovation Capital. Oligogen, Inc. demonstrates promise in the biotech and pharmaceutical industries, leveraging its innovative technologies to address critical unmet medical needs in the CNS therapeutic landscape.

Taxonomy: biotech startup, stem cell therapies, central nervous system diseases, neural stem cell technologies, OligoGenie, patented technology, pre-clinical phase, drug development, bio-venture, spinal cord injury

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round ¥111.05M 4
Nissay Capital SMBC Venture Capital Sosei CVC
Nissay Capital, SMBC Venture Capital +2
10 Aug 2017

Oligogen, Inc. Alternatives & Competitors

View All Alternatives
Oligogen, Inc. vs
Reviva Pharmaceuticals
Reviva Pharmaceuticals United States

Next Generation Therapeutics to successfully address central nervous system, metabolic and respirato...

Post-IPO Equity
18 employees
Biopharma, Biotechnology
Oligogen, Inc. vs
Cell BioEngines, Inc
Cell BioEngines, Inc United States

‘Off-the-Shelf’ Curative Cell Therapies

Pre-Seed
3 employees
Biotechnology, Health and Wellness
Oligogen, Inc. vs
Relmada Therapeutics, Inc
Relmada Therapeutics, Inc United States

Relmada (Nasdaq: $RLMD) is a clinical-stage company developing novel therapies for the treatment of...

Post-IPO Equity
32 employees
Biotechnology, Pharmaceutical
Also compare with: Oligogen, Inc. vs TreeFrog Therapeutics TreeFrog Therapeutics View all alternatives

FAQ About Oligogen, Inc.

Oligogen, Inc. is a biotech startup developing stem cell therapies for central nervous system diseases.
Oligogen, Inc. was founded in 2015.
Oligogen, Inc. is headquartered in Japan.
Oligogen, Inc. operates in Biotechnology, Care Economy, Health and Wellness and Pharmaceutical. Its work centres on biotech startup, stem cell therapies, central nervous system diseases and neural stem cell technologies.
Oligogen, Inc. has approximately 1 employees.
Oligogen, Inc. has completed 1 funding round, raising a total of $111.05M. The latest funding stage is Venture round.
Top alternatives and competitors to Oligogen, Inc. include Reviva Pharmaceuticals, Cell BioEngines, Inc, Relmada Therapeutics, Inc, Caribou Biosciences, TreeFrog Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Oligogen, Inc. and Reviva Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Oligogen, Inc., https://bouncewatch.com/company/oligogen-inc, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes